Contact
searchSearch
HMP Global
Login

Meeting Archive

Nataliya Uboha, MD, PhD
Conference Coverage
Cytoreductive Surgery Plus HIPEC for Patients With Gastric Cancers That Have Limited Peritoneal Carcinomatosis
06/20/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role cytoreductive surgery with HIPEC has for patients with gastric cancers that have peritoneal carcinomatosis.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role cytoreductive surgery with HIPEC has for patients with gastric cancers that have peritoneal carcinomatosis.
At Great Debates and Updates in...
06/20/2024
Oncology
Nataliya Uboha, MD, PhD
Conference Coverage
Role of Immunotherapy for Patients With Microsatellite Instability
06/20/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role immunotherapy can have in the treatment of patients with microsatellite instability.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Nataliya Uboha, MD, PhD, discusses the role immunotherapy can have in the treatment of patients with microsatellite instability.
At Great Debates and Updates in...
06/20/2024
Oncology
Michael Overman, MD
Conference Coverage
Is there a Role for Immune Therapy Outside of Clinical Trials for Patients With Proficient Mismatch Repair Colorectal Cancer?
06/20/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Overman, MD, explores whether or not there is a role for immune therapy in the treatment of patients with proficient mismatch repair colorectal...
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Overman, MD, explores whether or not there is a role for immune therapy in the treatment of patients with proficient mismatch repair colorectal...
At Great Debates and Updates in...
06/20/2024
Oncology
Michael Overman, MD
Conference Coverage
Doublet vs Singlet Immunotherapy for Patients With Metastatic MSI-High Colorectal Cancer
05/24/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Overman, MD, discussed advantages associated with treating patients with MSI-high colorectal cancer with doublet immunotherapy.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Overman, MD, discussed advantages associated with treating patients with MSI-high colorectal cancer with doublet immunotherapy.
At Great Debates and Updates in...
05/24/2024
Oncology
Michael Lidsky, MD
Conference Coverage
Hepatic Arterial Infusion Pump Therapy for Previously Treated Patients With Metastatic Colorectal Cancer
05/24/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Lidsky, MD, discussed ways researchers are working to overcome barriers to hepatic arterial infusion pump therapy limitations for patients with...
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Lidsky, MD, discussed ways researchers are working to overcome barriers to hepatic arterial infusion pump therapy limitations for patients with...
At Great Debates and Updates in...
05/24/2024
Oncology
Michael Hall, MD
Conference Coverage
Value of Germline Genetic Testing for All Patients With Gastrointestinal Cancers Irrespective of Tumor Origin
05/24/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Hall, MD, MS, discussed limitations to performing germline genetic testing on all patients with gastrointestinal cancers.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Michael Hall, MD, MS, discussed limitations to performing germline genetic testing on all patients with gastrointestinal cancers.
At Great Debates and Updates in...
05/24/2024
Oncology
Adam Talenfeld, MD
Conference Coverage
Transarterial Chemoembolization Plus Immunotherapy for Patients With Hepatocellular Carcinoma
05/23/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Adam Talenfeld, MD, argued in favor of using transarterial chemoembolization alongside immune checkpoint blockade to treat patients with hepatocellular...
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Adam Talenfeld, MD, argued in favor of using transarterial chemoembolization alongside immune checkpoint blockade to treat patients with hepatocellular...
At Great Debates and Updates in...
05/23/2024
Oncology
James Harding, MD
Conference Coverage
Transarterial Chemoembolization Plus Immune Checkpoint Blockade for Patients With Hepatocellular Carcinoma
05/22/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, James Harding, MD, discussed results from the EMERALD-1 study which demonstrated that transarterial chemoembolization plus immune checkpoint blockade...
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, James Harding, MD, discussed results from the EMERALD-1 study which demonstrated that transarterial chemoembolization plus immune checkpoint blockade...
At Great Debates and Updates in...
05/22/2024
Oncology
Jennifer Wo, MD
Conference Coverage
Consideration of Long Course Radiation for Patients With Rectal Cancer
05/21/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Jennifer Wo, MD, discussed use of long course neoadjuvant radiation therapy for the treatment of patients with rectal cancer.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Jennifer Wo, MD, discussed use of long course neoadjuvant radiation therapy for the treatment of patients with rectal cancer.
At Great Debates and Updates in...
05/21/2024
Oncology
Ryan Moy, MD
Conference Coverage
PD-1 Inhibitors for First-Line Treatment of Patients With Gastroesophageal Cancers
05/18/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Ryan Moy, MD, PhD, discussed first-line use of PD-1 inhibitors for the treatment of patients with gastroesophageal cancers.
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Ryan Moy, MD, PhD, discussed first-line use of PD-1 inhibitors for the treatment of patients with gastroesophageal cancers.
At Great Debates and Updates in...
05/18/2024
Oncology

About

At Great Debates and Updates in GI Malignancies, nationally recognized thought leaders take opposing sides on clinical, and sometimes controversial, topics currently disrupting the practice of gastrointestinal oncology.   

Through comprehensive review of the latest clinical advancements in gastrointestinal malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use